D Galasko, J Bell, JY Mancuso, JW Kupiec… - Neurology, 2014 - AAN Enterprises
Objective: To examine safety, tolerability, and efficacy of PF-04494700, an inhibitor of the
receptor for advanced glycation end products (RAGE), in mild to moderate Alzheimer …